Biomedical innovation, emerging technology, and health.
I’ve spent my career in biomedical innovation, focused on realizing the value of emerging molecular and digital technologies across biopharma R&D and digital health, including the promise and challenge of translating molecular and digital data into a deeper and ultimately more actionable understanding of individual health.
More recently, I’ve begun exploring another question: how might technology help cultivate agency and improve health? This is a central focus of my current work as Chief Medical Scientist at Lore Health.
Agency + health
A relatively new area of my work, growing out of my enduring belief in human possibility, asks: what does science tell us about preserving and enhancing health, rather than simply managing illness? Within that broader inquiry, I’m especially interested in the power and possibility of agency—our capacity to shape our lives—and how cultivating it might help us live better and improve our health. That interest is reflected in my current work at Lore.
Executive advisory
I serve as an executive advisor across biomedical innovation and science-based health technology, with particular depth in biopharma R&D and emerging digital technologies. Much of my work involves helping leaders navigate where new technologies genuinely add value—requiring attention to the nuances of science and organizational culture, as well as a feel for the human factors that often determine whether promising technologies are adopted and their potential realized.
Background
My career has included leadership roles in biopharma, health technology, and strategic venture investing. I’m currently Chief Medical Scientist at Lore Health, a lecturer in the Department of Biomedical Informatics at Harvard Medical School, and an adjunct fellow at the American Enterprise Institute.